Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Panpan Ma
Institutions:
Hunan University of Traditional Chinese Medicine,
Zhejiang University
Observed institutions:
Hunan University of Traditional Chinese Medicine,
Second Affiliated Hospital of Zhejiang University,
Zhejiang University
ORCID:
0009-0007-0911-1080
Observed ORCID:
0009-0007-0911-1080
OpenAlex ID:
A5019254149
Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2023
·
Wenhua Sang
, Yiduo Zhou
, et al.
·
Cancer Discovery
·
68
The Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer
2025
·
Wenyan Xie
, Xin Yu
, et al.
·
Cancer Discovery
·
59
Androsin alleviates colorectal cancer by inhibiting the PI3K/Akt-centered signaling pathway
2025
·
Yalun Zhang
, Huaihao Luo
, et al.
·
Korean Journal of Physiology and Pharmacology
·
1
Data from The Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer
2025
·
Wenyan Xie
, Xin Yu
, et al.
·
1
Table s8 from The Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer
2025
·
Wenyan Xie
, Xin Yu
, et al.
Supplementary Figures S1-S26 from The Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer
2025
·
Wenyan Xie
, Xin Yu
, et al.
Table s4 from The Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer
2025
·
Wenyan Xie
, Xin Yu
, et al.
Table s2 from The Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer
2025
·
Wenyan Xie
, Xin Yu
, et al.
Table s1 from The Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer
2025
·
Wenyan Xie
, Xin Yu
, et al.
Table s5 from The Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer
2025
·
Wenyan Xie
, Xin Yu
, et al.
Table s3 from The Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer
2025
·
Wenyan Xie
, Xin Yu
, et al.
Table s6 from The Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer
2025
·
Wenyan Xie
, Xin Yu
, et al.
Table s7 from The Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer
2025
·
Wenyan Xie
, Xin Yu
, et al.
Nuclear stiffening in neoplastic cells aggregates T cell exhaustion via pFAK/SP1/IL-6 axis in colorectal cancer
2024
·
Hao Kong
, Xiangji Wu
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Data from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S3 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
SUPPLEMENTARY DATA FIGURES from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S1 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S2 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Data from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S4 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Data from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
SUPPLEMENTARY DATA FIGURES from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
PDF
Supplementary Table S2 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S2 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Show more works
View as search
Works count:
30
Citation count:
129
H-index:
2
I10-index:
2
Year
Topic
Type